Trial Profile
A Double-blind, Placebo-controlled, Randomized, Single Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MDCO-2010 in Patients Undergoing Elective CABG Surgery
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Apr 2018
Price :
$35
*
At a glance
- Drugs MDCO 2010 (Primary)
- Indications Thrombosis
- Focus Adverse reactions
- Sponsors The Medicines Company
- 25 Oct 2011 New trial record
- 19 Oct 2011 Results presented at the 2011 Annual Meeting of the American Society of Anesthesiologists.